FDA NDC Directory · JSON-LD · Markdown

Lansoprazole

NDC 27241-019 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203957
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (15 mg/1)
Marketing started20161018
Package count2

External sources

Source: openFDA. Public-domain (CC0).